Tissue engineered vessel from a biodegradable electrospun scaffold stimulated with mechanical stretch
Source abstract
Abstract
Abstract A tissue engineered vessel has the potential to provide an alternative small diameter vascular graft for patients with cardiovascular disease in need of surgical revascularization. In this study, a polyglycolic acid (PGA) electrospun scaffold seeded with human dermal fibroblasts was stimulated with circumferential mechanical stretch by a pulsatile perfusion system. The PGA scaffold was fabricated using a custom electrospinning set-up to co-electrospray a sacrificial polyethylene oxide microparticle to increase pore size and bulk porosity. The tissue engineered vessel exposed to circumferential mechanical stretch was compared to an engineered vessel cultured under static conditions without any mechanical stimulation. The histology cross-sections demonstrated a similar thickness of engineered vessels with mechanical stretch and static, but on Masson’s Trichrome stain there was nearly twice the amount of staining for collagen. The collagen content was quantified, and the collagen content was 60% greater in the human tissue engineered vessel exposed to mechanical stretch compared to the static vessel. The total collagen cross-linking was similar, but on a per collagen basis there was significantly more cross-linking in the static vessel over the stretch vessel. The stress-strain curve of the tissue engineered vessel with mechanical stretch demonstrated a statistically significantly greater ultimate tensile strength (UTS) of 1.86 ± 0.14 MPa (n = 6) and elastic modulus (EM) of 7.62 ± 0.39 MPa (n = 6) versus the static engineered vessel UTS of 0.31 ± 0.07 MPa (n = 5) and EM of 1.37 ± 0.21 MPa (n = 5). The primary determinant of the mechanical properties of the tissue engineered vessel correlated to the collagen content with minimal contribution of the collagen cross-linking. Therefore, the versatile properties of an electrospun scaffold are ideal in combination with a biomimetic culture system to generate a tissue engineered vessel composed of extracellular matrix suitable as a vascular graft.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Tissue Engineering and Regenerative Medicine · Bone Tissue Engineering Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (47)
Show source-provided references
1. Deaths: leading causes for 2016
2. Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions10.1016/0741-5214(86)90073-X ↗
3. Preoperative saphenous venography in arterial reconstructive surgery of the lower extremity
4. Cryopreserved saphenous vein allografts in infrainguinal revascularization: analysis of 240 grafts10.1016/S0741-5214(03)00330-6 ↗
5. A completely biological tissue-engineered human blood vessel
6. Functional arteries grown in vitro10.1126/science.284.5413.489 ↗
7. Implantable arterial grafts from human fibroblasts and fibrin using a multi-graft pulsed flow-stretch bioreactor with noninvasive strength monitoring10.1016/j.biomaterials.2010.09.019 ↗
8. First human use of an allogeneic tissue-engineered vascular graft for hemodialysis access10.5301/jva.2011.6360 ↗
9. Decellularized native and engineered arterial scaffolds for transplantation10.3727/000000003108747136 ↗
10. Implantation of completely biological engineered grafts following decellularization into the sheep femoral artery10.1089/ten.tea.2013.0550 ↗
11. Bioengineered human acellular vessels for dialysis access in patients with end-stage renal disease: two phase 2 single-arm trials10.1016/S0140-6736(16)00557-2 ↗
12. Advancements in electrospinning of polymeric nanofibrous scaffolds for tissue engineering10.1089/ten.teb.2013.0276 ↗
13. Electrospun vascular scaffold for cellularized small diameter blood vessels: a preclinical large animal study10.1016/j.actbio.2017.06.027 ↗
14. Porcine carotid artery replacement with biodegradable electrospun poly-e-caprolactone vascular prosthesis10.1016/j.jvs.2013.03.004 ↗
15. Creation of macropores in electrospun silk fibroin scaffolds using sacrificial PEO-microparticles to enhance cellular infiltration10.1002/jbm.a.34656 ↗
16. Degradation and healing characteristics of small-diameter poly(ϵ-caprolactone) vascular grafts in the rat systemic arterial circulation10.1161/CIRCULATIONAHA.108.795732 ↗
17. Calcification in arteriovenous fistula blood vessels may predict arteriovenous fistula failure: a 5-year follow-up study10.1007/s11255-017-1515-0 ↗
18. Vascular tissue engineering of small-diameter blood vessels: reviewing the electrospinning approach10.1002/term.1697 ↗
19. Effect of scaffold material, construct length and mechanical stimulation on the in vitro stiffness of the engineered tendon construct10.1016/j.jbiomech.2007.11.009 ↗
20. Uniaxial strain regulates morphogenesis, gene expression, and tissue strength in engineered skin10.1089/ten.tea.2009.0542 ↗
21. The independent role of cyclic flexure in the early in vitro development of an engineered heart valve tissue10.1016/j.biomaterials.2004.02.035 ↗
22. Effects of mechanical stretch on collagen and cross-linking in engineered blood vessels10.3727/096368909X471161 ↗
23. TGF-β1 diminishes collagen production during long-term cyclic stretching of engineered connective tissue: implication of decreased ERK signaling10.1016/j.jbiomech.2010.12.007 ↗
24. Mechanisms of maturation and ageing of collagen10.1016/S0047-6374(98)00119-5 ↗
25. Advances in collagen cross-link analysis10.1016/j.ymeth.2008.01.002 ↗
26. Advanced glycation end-products diminish tendon collagen fiber sliding10.1016/j.matbio.2013.01.003 ↗
27. Aminoguanidine prevents age-related arterial stiffening and cardiac hypertrophy10.1073/pnas.95.3.1301 ↗
28. Fracture mechanics of collagen fibrils: influence of natural cross-links10.1016/j.bpj.2013.04.033 ↗
29. Electrospun PGA/gelatin nanofibrous scaffolds and their potential application in vascular tissue engineering10.2147/IJN.S24312 ↗
30. The improvement of cell infiltration in an electrospun scaffold with multiple synthetic biodegradable polymers using sacrificial PEO microparticles10.1002/jbm.a.36706 ↗
31. Decellularized tissue-engineered blood vessel as an arterial conduit10.1073/pnas.1019506108 ↗
32. Quantitative method for biomarkers of collagen degradation using liquid chromatography tandem mass spectrometry10.1006/abio.2000.4625 ↗
33. Species-specific effects of aortic valve decellularization10.1016/j.actbio.2017.01.008 ↗
34. Preparation of porcine carotid arteries for vascular tissue engineering applications10.1002/jbm.a.30060 ↗
35. Biomechanical properties of decellularized porcine common carotid arteries10.1152/ajpheart.00564.2004 ↗
36. Mechanical properties of completely autologous human tissue engineered blood vessels compared to human saphenous vein and mammary artery10.1016/j.biomaterials.2008.11.011 ↗
37. Readily available tissue-engineered vascular grafts10.1126/scitranslmed.3001426 ↗
38. Electrospinning of polymeric nanofibers for tissue engineering applications: a review10.1089/ten.2006.12.1197 ↗
39. Cyclic distension of fibrin-based tissue constructs: evidence of adaptation during growth of engineered connective tissue10.1073/pnas.0711217105 ↗
40. An introductory review of cell mechanobiology10.1007/s10237-005-0012-z ↗
41. Mechanical stretch activates the stress-activated protein kinases in cardiac myocytes10.1096/fasebj.10.5.8621062 ↗
42. Effects of intermittent and incremental cyclic stretch on ERK signaling and collagen production in engineered tissue10.1007/s12195-015-0415-6 ↗
43. Glutaraldehyde cross-linking of tendon–mechanical effects at the level of the tendon fascicle and fibril10.1080/03008200802610040 ↗
44. Micromechanical analysis of native and cross-linked collagen type I fibrils supports the existence of microfibrils10.1016/j.jmbbm.2011.11.008 ↗
45. Role of collagen content and cross-linking in large pulmonary arterial stiffening after chronic hypoxia10.1007/s10237-011-0309-z ↗
46. Cross-link stabilization does not affect the response of collagen molecules, fibrils, or tendons to tensile overload10.1002/jor.22460 ↗
47. Negative consequences of glycation10.1016/S0026-0495(00)80078-5 ↗